Levodopa for restless legs syndrome
Referencias
Additional references
Allen RP, Picchietti D, Hening WA, Trenkwalder C, Walters AS, Montplaisir J. Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health. Sleep Medicine 2003;4:101‐119.
Berger K, Luedemann J, Trenkwalder C, John U, Kessler C. Parity and the risk of restless legs syndrome in the general population. Archives of Internal Medicine 2004;164(2):196‐202.
Eisensehr I, Ehrenberg BL, Rogge Solti S, Noachtar S. Treatment of idiopathic restless legs syndrome (RLS) with slow‐release valproic acid compared with slow‐release levodopa/ benserazid. Journal of Neurology 2004;251:579‐583.
Garcia‐Borreguero D, Larrosa O, de la Llave Y, Verger K, Masramon X, Hernandez G. Treatment of restless legs syndrome with gabapentin: a double‐blind, cross‐over study. Neurology 2002;59(10):1573‐1579.
Happe S, Trenkwalder C. Role of dopamine receptor agonists in the treatment of restless legs syndrome. CNS Drugs 2004;18(1):27‐36.
Hening W, Allen RP, Earley C, Kushida C, Picchietti D, Silber M. The treatment of restless legs syndrome and periodic limb movement disorder ‐ an American Academy of Sleep Medicine Review. Sleep 1999;22:970‐998.
Hening W. The clinical neurophysiology of the restless legs syndrome and periodic limb movements. Part I: diagnosis, assessment, and characterization. Clinical Neurophysiology 2004;115(9):1965‐1974.
Hening W, Walters AS, Allen RP, Montplaisir J, Myers A, Ferini‐Strambi L. Impact, diagnosis and treatment of restless legs syndrome (RLS) in a primary care population: the REST (RLS epidemiology, symptoms, and treatment) primary care study. Sleep Medicine 2004;5(3):237‐246.
Hening WA, Allen RP, Earley CJ, Picchietti DL, Silber MH, Restless Legs Syndrome Task Force of the Standards of Practice Committee of the American Academy of Sleep Medicine. An update on the dopaminergic treatment of restless legs syndrome and periodic limb movement disorder. Sleep 2004;27(3):560‐583.
Hornyak M, Trenkwalder C. Restless legs syndrome and periodic limb movement disorder in the elderly. Journal of Psychosomatic Research 56:543‐548.
Högl B, Saletu M, Frauscher B, Brandauer E, Seppi K, Müller J, Gasperi A, Poewe. W, Kiechl S, Willeit J. Prevalence of Restless Legs Syndrome in the central European alpine region of South Tyrol. Sleep 2003;26:A344.
Phillips B, Young T, Finn L, Asher K, Hening WA, Purvis C. Epidemiology of restless legs symptoms in adults. Archives of Internal medicine 2000;160:2137‐2141.
Alderson P, Green S, Higgins JPT, editors. Cochrane Reviewers' Handbook 4.2.2 [updated December 2003]. The Cochrane Library, Issue 1. Chichester, UK: John Wiley & Sons, Ltd, 2004.
Rothdach AJ, Trenkwalder C, Haberstock J, Keil U, Berger K. Prevalence and risk factors of RLS in an elderly population. Neurology 2000;54:1064‐1068.
Silber MH, Ehrenberg BL, Allen RP, Buchfuhrer MJ, Earley CJ, Hening WA, Rye DB, Medical Advisory Board of the Restless Legs Syndrome Foundation. An algorithm for the management of restless legs syndrome. Mayo Clinic Proceedings 2004;79(7):916‐922.
Trenkwalder C, Paulus W. Why do restless legs occur at rest?‐pathophysiology of neuronal structures in RLS. Neurophysiology of RLS (part 2). Clinical Neurophysiology 2004;115(9):1975‐1988.
Ulfberg J, Nyström B, Carter N, Edling C. Prevalence of restless legs syndrome among men aged 18 to 64 years: An association with somatic disease and neuropsychiatric symptoms. Movement Disorders 2001;16:1159‐1163.
Walters AS, Wagner ML, Hening WA, Grasing K, Mills R, Chokroverty S, Kavey N. Successful treatment of the idiopathic restless legs syndrome in a randomized double‐blind trial of oxycodone versus placebo. Sleep 1993;16:327‐332.
Walters AS, The International Restless Legs Syndrome Study Group. Toward a better definition of restless legs syndrome. Movement Disorders 1995;10:634‐642.
